EPB41L1 and non-small cell lung carcinoma: We report that promoter hypermethylation and aberrant miR-454-3p expression regulate 4.1N/EPB41L1 expression at transcriptional and posttranscriptional levels, respectively, but work in concert to restrict its expression in NSCLC.